Breaking News
Home / Medicine / Novavax Covid-19 vaccine trials still under way

Novavax Covid-19 vaccine trials still under way

New York – Top bosses at US pharmaceutical company, Novavax Inc, are not willing to wait and see how well their Covid-19 vaccine worksbefore reaping financial benefits, according to Reuters. Chief Executive Stanley Erck and three of his top lieutenants have sold roughly $46 million of company stock since the start of last year, according to a Reuters review of securities filings, capitalising on a near 3,000 per cent rally in Novavax shares fuelled by investors betting on the success of the shot under development. Erck cashed out $8.7 million over the course of 2020, eclipsing the $2.2m in shares he sold in the previous five years. The stock sale amounts to more than 20pc of his vested stake in Novavax, or less than 10pc if stock options that are yet to vest are counted, according to the review of the filings, an analysis by compensation consultant Farient Advisors LLC and a company spokeswoman. The lucrative liquidations, which have not previously been reported, underscore the transformation in Novavax’s fortunes during the global pandemic and the opportunity for its executives to lock in big profits from market optimism.

About eAwaz

eAwaz

Check Also

Australia concerned on deaths of 29 Norwegians after getting Pfizer vaccine

Sydney – Australian Health Minister Greg Hunt wants urgent information on the deaths of 29 …

Live Radio Stream